There’s a common (mis)conception that biotech stocks move only in response to an identifiable catalyst, so by this mode of thinking RVNC is “dead money” until 2020.
In fact, biotech stocks often make big moves when they are least expected.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.